NCT01743950 2026-03-25
A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab
University of Wisconsin, Madison
Phase 2 Terminated
Clinical Trials
13 trialsNCT06397573 2026-02-17
Ablative Stereotactic MR-Guided Adaptive Reirradiation
Baptist Health South Florida
Phase NA Active not recruiting
NCT03743662 2026-01-07
Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT05301101 2025-06-29
REDIRICT
Medical College of Wisconsin
Phase NA Recruiting
NCT02289209 2025-03-06
Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck
University of Pittsburgh
Phase 2 Completed
NCT03126266 2024-12-05
Re-Irradiation of Progressive or Recurrent DIPG
University of Calgary
Phase NA Completed
NCT03661723 2024-09-19
Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma
Dana-Farber Cancer Institute
Phase 2 Completed
NCT05666349 2024-03-26
RiNG
University College, London
Phase 1 Withdrawn
NCT06093165 2023-10-23
REMIT
Rigshospitalet, Denmark
Phase NA Not yet recruiting
NCT02745847 2023-05-25
Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer
Changhai Hospital
Phase NA Unknown
NCT01469247 2022-10-20
Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT03854838 2022-04-29
IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.
Sun Yat-sen University
Phase 2 Unknown
NCT00180934 2005-12-23
Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Unknown